Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies

Published:2020-12-03 Issue:S1 Volume:73 Page:49-61
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lu Xinjun¹²³,Paliogiannis Panagiotis⁴,Calvisi Diego F.⁵,Chen Xin²³^ORCID

Affiliation:

1. Department of Hepatic Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou China

2. Department of Bioengineering and Therapeutic Sciences University of California, San Francisco San Francisco CA

3. Liver Center University of California, San Francisco San Francisco CA

4. Department of Medical, Surgical, and Experimental Sciences University of Sassari Sassari Italy

5. Institute of Pathology University of Regensburg Regensburg Germany

Funder

China Scholarship Council

Liver Center, University of California, San Francisco

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31310

Reference64 articles.

1. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017

2. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

4. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

5. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FGF21 upregulation by hepatitis C virus via the eIF2α-ATF4 pathway: implications for interferon signaling suppression and TRIM31-mediated TSC degradation;Frontiers in Microbiology;2024-08-15

2. SMYD5 is a ribosomal methyltransferase that catalyzes RPL40 lysine methylation to enhance translation output and promote hepatocellular carcinoma;Cell Research;2024-08-05

3. Excitatory amino acid transporter supports inflammatory macrophage responses;Science Bulletin;2024-08

4. ELOVL1 is upregulated and promotes tumor growth in hepatocellular carcinoma through regulating PI3K-AKT-mTOR signaling;Heliyon;2024-08

5. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3